A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...

The genetics company is closing a unit that was once seen as core to its future.

A cutting-edge genetic test can rapidly detect and identify almost any kind of disease-causing microorganism in the human ...

23andMe currently lists two assets in early-stage testing. First ... The dual-mechanism drug targets ULBP6, which is secreted ...

Increased awareness of genetic testing’s role in disease prevention is driving market growth. Saudi Arabia's genetic testing ...

Ibuprofen counters problems caused by mutations in the MAN1B1 gene, fruit fly tests show. Early results in three children are ”fairly positive.” ...

focusing instead on selling genetic tests to consumers and using the resulting data for research. In closing its therapeutics ...

In line with the restructuring initiative, 23andMe is looking for strategic opportunities for its pipeline assets, including ...

When the two drugs were given in combination, it led to lasting tumor regression without the development of resistance. In healthy human cells, DNA is neatly packaged into bundles called chromosomes.

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Here's what's blowing in the wind in Bay Area business to get your Tuesday morning started: Marqeta, 23andMe, Enphase Energy, ...